Mary Plank
Obstetrics & Gynecology · Dallas, TXNPI 1508893876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 27.9% of the total. Reporting peaked in 2019 at $480 and has fallen 59.3% since, to $196 in 2024.
Across 70 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$404
- Hologic Sales And Service, LLC$223
- Astellas Pharma US Inc$169
- Sumitomo Pharma America, Inc.$89
- Exeltis, USA Inc.$79
- Minerva Surgical, Inc$76
- plus $409 from 16 others
What the payments were for
- Food & beverage$1,33392%
- Education$1168%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $404 |
| Hologic Sales And Service, LLC | 8 | $223 |
| Astellas Pharma US Inc | 4 | $169 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Exeltis, USA Inc. | 4 | $79 |
| Minerva Surgical, Inc | 4 | $76 |
| Smith+Nephew | 4 | $65 |
| Organon | 3 | $60 |
| Merck | 3 | $36 |
| Myovant Sciences Inc. | 2 | $33 |
| Coopersurgical, Inc. | 2 | $27 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Acessa Health Inc. | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $14 |
| Lupin Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $11 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
How this compares
$1,449 in reported general payments places this provider in the 60th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Dallas
- Dale StovallDallas$590K
- Quanita CrableDallas$176K
- Kamilia SmithDallas$119K
- Yolanda LawsonDallas$96K
- Patrick WeixDallas$96K
- David RogersDallas$44K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.